Insomnia Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Insomnia Market to 2027 - Global Analysis and Forecasts By Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) and Geography

Report Code: TIPRE00005214 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Insomnia is a condition in which a person faces difficulty while falling asleep, waking up during sleep and as well as feeling tired on waking. Insomnia is linked with other health problems like asthma, depression, arthritis or pain. The causes of insomnia can be included such as depression, stress, illness and emotional or physical discomfort.

MARKET DYNAMICS
The insomnia market is anticipated to grow in the forecast period owing to increasing prevalence of insomnia and growing demand for its innovative treatment, emergence of therapeutics with fewer side effects as well as stressful work and working in shifts. Moreover, rise in demand for OTC sleep aids is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Insomnia Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of insomnia market with detailed market segmentation by drug class, distribution channel and geography. The global insomnia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading insomnia market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global insomnia market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is classified as antidepressants, melatonin antagonist, benzodiazepines, nonbenzodiazepines, orexin and antagonist. On the basis of distribution channel the insomnia market is divided as Hospital Pharmacies, Retail Pharmacies, Drug Stores and Online Pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global insomnia market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The insomnia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting insomnia market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the insomnia market in these regions.

MARKET PLAYERS
The reports cover key developments in the insomnia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from insomnia market are anticipated to lucrative growth opportunities in the future with the rising demand for insomnia market in the global market. Below mentioned is the list of few companies engaged in the insomnia market.
The report also includes the profiles of key insomnia market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Mallinckrodt
  • Eisai Co., Ltd.
  • Merck Sharp & Dohme Corp. (Merck & Co., Inc)
  • Galt Pharmaceuticals, LLC.
  • Pfizer Inc.
  • Sanofi
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Vanda Pharmaceuticals
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Insomnia Market - By Drug Class
1.3.2 Insomnia Market - By Distribution Channel
1.3.3 Insomnia Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INSOMNIA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INSOMNIA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INSOMNIA MARKET - GLOBAL MARKET ANALYSIS
6.1. INSOMNIA - GLOBAL MARKET OVERVIEW
6.2. INSOMNIA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INSOMNIA MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIDEPRESSANTS
7.3.1. Overview
7.3.2. Antidepressants Market Forecast and Analysis
7.4. MELATONIN ANTAGONIST
7.4.1. Overview
7.4.2. Melatonin Antagonist Market Forecast and Analysis
7.5. BENZODIAZEPINES
7.5.1. Overview
7.5.2. Benzodiazepines Market Forecast and Analysis
7.6. NONBENZODIAZEPINES
7.6.1. Overview
7.6.2. Nonbenzodiazepines Market Forecast and Analysis
7.7. OREXIN ANTAGONIST
7.7.1. Overview
7.7.2. Orexin Antagonist Market Forecast and Analysis
8. INSOMNIA MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. ONLINE PHARMACIES
8.6.1. Overview
8.6.2. Online Pharmacies Market Forecast and Analysis
9. INSOMNIA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Insomnia Market Overview
9.1.2 North America Insomnia Market Forecasts and Analysis
9.1.3 North America Insomnia Market Forecasts and Analysis - By Drug Class
9.1.4 North America Insomnia Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Insomnia Market Forecasts and Analysis - By Countries
9.1.5.1 United States Insomnia Market
9.1.5.1.1 United States Insomnia Market by Drug Class
9.1.5.1.2 United States Insomnia Market by Distribution Channel
9.1.5.2 Canada Insomnia Market
9.1.5.2.1 Canada Insomnia Market by Drug Class
9.1.5.2.2 Canada Insomnia Market by Distribution Channel
9.1.5.3 Mexico Insomnia Market
9.1.5.3.1 Mexico Insomnia Market by Drug Class
9.1.5.3.2 Mexico Insomnia Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Insomnia Market Overview
9.2.2 Europe Insomnia Market Forecasts and Analysis
9.2.3 Europe Insomnia Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Insomnia Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Insomnia Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Insomnia Market
9.2.5.1.1 Germany Insomnia Market by Drug Class
9.2.5.1.2 Germany Insomnia Market by Distribution Channel
9.2.5.2 France Insomnia Market
9.2.5.2.1 France Insomnia Market by Drug Class
9.2.5.2.2 France Insomnia Market by Distribution Channel
9.2.5.3 Italy Insomnia Market
9.2.5.3.1 Italy Insomnia Market by Drug Class
9.2.5.3.2 Italy Insomnia Market by Distribution Channel
9.2.5.4 Spain Insomnia Market
9.2.5.4.1 Spain Insomnia Market by Drug Class
9.2.5.4.2 Spain Insomnia Market by Distribution Channel
9.2.5.5 United Kingdom Insomnia Market
9.2.5.5.1 United Kingdom Insomnia Market by Drug Class
9.2.5.5.2 United Kingdom Insomnia Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Insomnia Market Overview
9.3.2 Asia-Pacific Insomnia Market Forecasts and Analysis
9.3.3 Asia-Pacific Insomnia Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Insomnia Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Insomnia Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Insomnia Market
9.3.5.1.1 Australia Insomnia Market by Drug Class
9.3.5.1.2 Australia Insomnia Market by Distribution Channel
9.3.5.2 China Insomnia Market
9.3.5.2.1 China Insomnia Market by Drug Class
9.3.5.2.2 China Insomnia Market by Distribution Channel
9.3.5.3 India Insomnia Market
9.3.5.3.1 India Insomnia Market by Drug Class
9.3.5.3.2 India Insomnia Market by Distribution Channel
9.3.5.4 Japan Insomnia Market
9.3.5.4.1 Japan Insomnia Market by Drug Class
9.3.5.4.2 Japan Insomnia Market by Distribution Channel
9.3.5.5 South Korea Insomnia Market
9.3.5.5.1 South Korea Insomnia Market by Drug Class
9.3.5.5.2 South Korea Insomnia Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Insomnia Market Overview
9.4.2 Middle East and Africa Insomnia Market Forecasts and Analysis
9.4.3 Middle East and Africa Insomnia Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Insomnia Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Insomnia Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Insomnia Market
9.4.5.1.1 South Africa Insomnia Market by Drug Class
9.4.5.1.2 South Africa Insomnia Market by Distribution Channel
9.4.5.2 Saudi Arabia Insomnia Market
9.4.5.2.1 Saudi Arabia Insomnia Market by Drug Class
9.4.5.2.2 Saudi Arabia Insomnia Market by Distribution Channel
9.4.5.3 U.A.E Insomnia Market
9.4.5.3.1 U.A.E Insomnia Market by Drug Class
9.4.5.3.2 U.A.E Insomnia Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Insomnia Market Overview
9.5.2 South and Central America Insomnia Market Forecasts and Analysis
9.5.3 South and Central America Insomnia Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Insomnia Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Insomnia Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Insomnia Market
9.5.5.1.1 Brazil Insomnia Market by Drug Class
9.5.5.1.2 Brazil Insomnia Market by Distribution Channel
9.5.5.2 Argentina Insomnia Market
9.5.5.2.1 Argentina Insomnia Market by Drug Class
9.5.5.2.2 Argentina Insomnia Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. INSOMNIA MARKET, KEY COMPANY PROFILES
11.1. MALLINCKRODT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EISAI CO., LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK SHARP AND DOHME CORP. (MERCK AND CO., INC)
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GALT PHARMACEUTICALS, LLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. PFIZER INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SANOFI
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SUMITOMO DAINIPPON PHARMA CO., LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VANDA PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Mallinckrodt
2. Eisai Co., Ltd.
3. Merck Sharp & Dohme Corp. (Merck & Co., Inc)
4. Galt Pharmaceuticals, LLC.
5. Pfizer Inc.
6. Sanofi
7. Sumitomo Dainippon Pharma Co., Ltd.
8. Takeda Pharmaceutical Company Limited
9. Teva Pharmaceutical Industries Ltd.
10. Vanda Pharmaceuticals